Genmab | GEN - Ebitda





Ebitda 変化する 日付
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Almirall EUR 80.45M 33.61M 2026-06
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.8B 1.25B 2026-09
argenx SE USD 539M 6M 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Bayer EUR 1.62B 529M 2026-09
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Demant DKK 2.8B 47M 2026-06
Exelixis USD 275.36M 19.96M 2026-09
Fresenius Medical Care EUR 817M 26.66M 2026-09
Genmab DKK 401M 186M 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
GN Store Nord DKK 354M 2M 2026-09
GRIFOLS EUR 505M 32M 2026-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Insmed USD -80.97M 93.7M 2026-09
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.6B 69M 2026-06
Novartis USD 8.62B 2.14B 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
UCB EUR 1.6B 570M 2025-12